glp 1 atherosclerosis GLP-1 receptor agonists and protection: the vascular endothelium takes center stage | American Journal of Physiology-Heart and Circulatory Physiology Current Perspectives on GLP-1 Agonists
Description
Porter et al., 2013)
The trial met its co-primary endpoints, demonstrating that up to 97% of patients taking the China-developed drug achieved at least 5% weight loss, according to Regeneron's press release
Mechanisms of biphasic insulin-granule exocytosisroles of the cytoskeleton, small GTPases and SNARE proteins
Islington, London, UK: Reaktion Books (2018)
